TME Pharma receives US FDA Fast Track designation for lead asset NOX-A12 in brain cancer
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
This agreement between Thermo Fisher Scientific and Aesku gives customers access to a comprehensive portfolio of autoimm…
Berlin is known for being one of the most creative and vibrant cities in Europe. Therefore, it's no surprise that this y…
83% of glioblastoma patients remain alive after 15 months on study, unchanged from the 14-month survival update 15-month…
Sibanye Stillwater Limited (Sibanye-Stillwater or the Group - https://www.commodity-tv.com/...) (JSE: SSW and NYSE: SBS…
Update covers data from 11 heavily pre-treated, last-line patients in Phase 1b dose expansion Cohort A treated with IMA2…
The University Hospital Aalborg (Denmark) yesterday has imaged the first patient with Eckert and Ziegler’s Gallium (68Ga…
One PhD student and two postdocs have received the first ibidi Paper Award for successfully publishing their findings in…
The integrated, battery-operated IO-Link Wireless based solution enables a unique real-time measurement of the clamping…
Attgeno AB today announces a research collaboration targeting to explore Supernitro (PDNO) as a new potential treatment…